Mapping and phenotypic analysis of spontaneous isatin-beta-thiosemicarbazone resistant mutants of vaccinia virus.
Treatment of wild type vaccinia virus infected cells with the anti-poxviral drug isatin-beta-thiosemicarbazone (IBT) induces the viral postreplicative transcription apparatus to synthesize longer-than-normal mRNAs through an unknown mechanism. Previous studies have shown that virus mutants resistant to or dependent on IBT affect genes involved in control of viral postreplicative transcription elongation. This study was initiated in order to identify additional viral genes involved in control of vaccinia postreplicative transcription elongation. Eight independent, spontaneous IBT resistant mutants of vaccinia virus were isolated. Marker rescue experiments mapped two mutants to gene G2R, which encodes a previously characterized postreplicative gene positive transcription elongation factor. Three mutants mapped to the largest subunit of the viral RNA polymerase, rpo147, the product of gene J6R. One mutant contained missense mutations in both G2R and A24R (rpo132, the second largest subunit of the RNA polymerase). Two mutants could not be mapped, however sequence analysis demonstrated that neither of these mutants contained mutations in previously identified IBT resistance or dependence genes. Phenotypic and biochemical analysis of the mutants suggests that they possess defects in transcription elongation that compensate for the elongation enhancing effects of IBT. The results implicate the largest subunit of the RNA polymerase (rpo147) in the control of elongation, and suggest that there exist additional gene products which mediate intermediate and late transcription elongation in vaccinia virus.
Cresawn
Steven G
SG
Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA.
Prins
Cindy
C
Latner
Donald R
DR
Condit
Richard C
RC
D000818:Animals; D020134:Catalytic Domain / Q000235:genetics; D002460:Cell Line; D012321:DNA-Directed RNA Polymerases / Q000737:chemistry / Q000235:genetics*; D024882:Drug Resistance, Viral; D020869:Gene Expression Profiling; D015967:Gene Expression Regulation, Viral; D006801:Humans; D007510:Isatin / Q000031:analogs & derivatives / Q000494:pharmacology; D008956:Models, Chemical; D009154:Mutation; D010445:Peptide Elongation Factors; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism; D035602:Transcriptional Elongation Factors / Q000235:genetics; D014616:Vaccinia virus / Q000187:drug effects / Q000235:genetics*; D014764:Viral Proteins / Q000737:chemistry / Q000235:genetics*
D010445:Peptide Elongation Factors; D012333:RNA, Messenger; D012367:RNA, Viral; D035602:Transcriptional Elongation Factors; D014764:Viral Proteins; C013578:isatin beta-thiosemicarbazone; D007510:Isatin; D012321:DNA-Directed RNA Polymerases